rs116343381
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_014956.5(CEP164):c.1639G>A(p.Glu547Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000532 in 1,614,130 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_014956.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEP164 | NM_014956.5 | c.1639G>A | p.Glu547Lys | missense_variant | 14/33 | ENST00000278935.8 | NP_055771.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEP164 | ENST00000278935.8 | c.1639G>A | p.Glu547Lys | missense_variant | 14/33 | 1 | NM_014956.5 | ENSP00000278935 | P1 | |
CEP164 | ENST00000529153.5 | n.126G>A | non_coding_transcript_exon_variant | 1/4 | 4 | |||||
CEP164 | ENST00000533706.5 | n.963G>A | non_coding_transcript_exon_variant | 7/27 | 5 | |||||
CEP164 | ENST00000533675.5 | n.1832+989G>A | intron_variant, non_coding_transcript_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00286 AC: 435AN: 152214Hom.: 3 Cov.: 32
GnomAD3 exomes AF: 0.000668 AC: 168AN: 251316Hom.: 1 AF XY: 0.000589 AC XY: 80AN XY: 135820
GnomAD4 exome AF: 0.000289 AC: 423AN: 1461798Hom.: 3 Cov.: 30 AF XY: 0.000252 AC XY: 183AN XY: 727206
GnomAD4 genome AF: 0.00286 AC: 435AN: 152332Hom.: 3 Cov.: 32 AF XY: 0.00285 AC XY: 212AN XY: 74484
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 26, 2016 | - - |
CEP164-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 26, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Nephronophthisis 15 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at